AQbD enabled optimization of RP-HPLC method for the estimation of pioglitazone and vildagliptin and its forced degradation studies
Background: Diabetes mellitus is a metabolic disorder that is managed with combination therapy. Pioglitazone improves insulin sensitivity by activating PPAR-γ, whereas vildagliptin increases incretin activity by inhibiting DPP-4. Their fixed-dose combination requires reliable analytical methods for...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Creative Pharma Assent
2026-05-01
|
| Serie: | Journal of Applied Pharmaceutical Research |
| Ämnen: | |
| Länkar: | https://japtronline.com/index.php/joapr/article/view/1856 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|